A new analysis from Michigan Medicine shows that despite having a much higher risk of serious illness or death from COVID-19, individuals with sickle cell disease are much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus. Sarah Reeves, Ph.D. principal investigator at the Michigan Sickle Cell Data Collection Program, shares insights from the study, highlighting the importance of accessibility of these vaccines.
